enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Robitussin cough syrup recall issued nationwide due to ... - AOL

   www.aol.com/robitussin-cough-syrup-recall-issued...

   Robitussin Honey CF Max Day and Nighttime are cough syrups indicted for the temporary relief of symptoms occurring with cold or flu, hay fever, or other respiratory allergies, according to Haleon.

3. Dextromethorphan - Wikipedia

   en.wikipedia.org/wiki/Dextromethorphan

   Dextromethorphan, sold under the brand name Robitussin among others, is a cough suppressant used in many cough and cold medicines. [6] In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder .

4. 8 Lots of This Popular Cough Syrup Have Been Recalled ... - AOL

   www.aol.com/8-lots-popular-cough-syrup-202500662...

   That said, immunocompromised people who used Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups from the recalled lots may be at risk of fungemia (fungi or ...

5. Robitussin maker recalls several lots of cough syrup due to ...

   www.aol.com/news/robitussin-maker-recalls...

   The maker of Robitussin cough syrup is recalling several lots of products containing honey due to contamination that could pose a serious risk to people with weakened immune systems. Haleon’s ...

6. Guaifenesin/codeine - Wikipedia

   en.wikipedia.org/wiki/Guaifenesin/codeine

   Guaifenesin/codeine is a fixed-dose combination cold medicine used for the treatment of cough. [1] It contains guaifenesin, an expectorant; and codeine, as the phosphate, an opioid antitussive. [1] It is taken by mouth. [1] It was approved for medical use in the United States in 2006. [1]

7. Dextromethorphan regulation by U.S. jurisdiction - Wikipedia

   en.wikipedia.org/wiki/Dextromethorphan...

   Michigan Governor Gretchen Whitmer signed HB 4412, legislation to combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) by prohibiting the sale of DXM-containing products to minors without a prescription. The new law went into effect on July 1, 2020.